Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Polio vaccine
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Vaccine to prevent poliomyelitis}} {{Good article}} {{Use dmy dates|date=July 2024}} {{cs1 config |name-list-style=vanc |display-authors=6}} {{Infobox drug | Verifiedfields = changed | verifiedrevid = 450061491 | image = Poliodrops.jpg <!-- Vaccine data -->| type = vaccine | target = [[Poliomyelitis]] | vaccine_type = IPV: inactivated<br/>OPV: attenuated<br/>nOPV2: attenuated, genetically stabilised <!-- Clinical data -->| tradename = Ipol, Poliovax, others | licence_CA = Imovax | Drugs.com = {{drugs.com|monograph|poliovirus-vaccine-inactivated}} | MedlinePlus = a601177 | DailyMedID = Ipol | pregnancy_AU = B2 | pregnancy_AU_comment = <ref name="Drugs.com pregnancy">{{drugs.com|pregnancy|poliovirus-vaccine-inactivated}}</ref> | pregnancy_category = | legal_AU = | legal_CA = <!-- I, II, III, IV, V, VI, VII, VIII --> | legal_UK = | legal_US = Rx-only | legal_status = | routes_of_administration = IPV: [[parenteral]]<br/>OPV: [[oral administration|oral]] | ATC_prefix = J07 | ATC_suffix = BF01 | ATC_supplemental = {{ATC|J07|BF02}} {{ATC|J07|BF03}} {{ATC|J07|BF04}} <!-- Identifiers -->| CAS_number = 1008119-78-5 | PubChem = | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB10796 | DrugBank2 = DB10797 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID = None }} <!-- Definition and medical uses --> '''Polio vaccines''' are [[vaccine]]s used to prevent [[poliomyelitis]] (polio).<ref name=WHO2016/><ref name=WHO2022>{{cite journal | vauthors = ((World Health Organization)) | title = Polio vaccines: WHO position paper β June 2022 | journal = Weekly Epidemiological Record | volume = 97 | issue = 25 | pages = 277β300 | date = 2022 | hdl=10665/357168 | hdl-access = free | author-link = World Health Organization }}</ref> Two types are used: an [[inactivated vaccine|inactivated]] poliovirus given by injection (IPV) and a [[attenuated vaccine|weakened]] poliovirus given by mouth (OPV).<ref name=WHO2016/> The [[World Health Organization]] (WHO) recommends all children be fully vaccinated against polio.<ref name=WHO2016/> The two vaccines have eliminated polio from most of the world,<ref name="Aylward_2006">{{cite journal|vauthors=Aylward RB|year=2006|title=Eradicating polio: today's challenges and tomorrow's legacy|journal=Annals of Tropical Medicine and Parasitology|volume=100|issue=5β6|pages=401β413|doi=10.1179/136485906X97354|pmid=16899145|s2cid=25327986}}</ref><ref>{{cite journal|vauthors=Schonberger LB, Kaplan J, Kim-Farley R, Moore M, Eddins DL, Hatch M|year=1984|title=Control of paralytic poliomyelitis in the United States|journal=Reviews of Infectious Diseases|volume=6 | issue = Suppl 2|pages=S424βS426|doi=10.1093/clinids/6.Supplement_2.S424|pmid=6740085}}</ref> and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.<ref name="gwp2013">{{cite web|url=http://polioeradication.org/wp-content/uploads/2019/02/global-wild-poliovirus-2013-2018-20190201.pdf|title=Global Wild Poliovirus 2014β2019|access-date=3 February 2019|archive-date=3 February 2019|archive-url=https://web.archive.org/web/20190203085212/http://polioeradication.org/wp-content/uploads/2019/02/global-wild-poliovirus-2013-2018-20190201.pdf|url-status=live}}</ref><ref>{{Cite web|url=https://www.who.int/features/qa/07/en/|title=Does polio still exist? Is it curable?|website=[[World Health Organization]] (WHO)|access-date=21 May 2018|archive-date=29 May 2018|archive-url=https://web.archive.org/web/20180529121019/http://www.who.int/features/qa/07/en/|url-status=live}}</ref> <!-- Safety --> The inactivated polio vaccines are very safe.<ref name=WHO2016/> Mild redness or pain may occur at the site of injection.<ref name=WHO2016/> Oral polio vaccines cause about three cases of vaccine-associated paralytic poliomyelitis per million doses given.<ref name=WHO2016/> This compares with 5,000 cases per million who are paralysed following a polio infection.<ref name="WHO2017Fs114">{{Cite web|url=https://www.who.int/mediacentre/factsheets/fs114/en/|title=Poliomyelitis|website=[[World Health Organization]] (WHO)|archive-url=https://web.archive.org/web/20170418105535/http://www.who.int/mediacentre/factsheets/fs114/en/|archive-date=18 April 2017|url-status = live|access-date=25 April 2017}}</ref> Both types of vaccine are generally safe to give during [[pregnancy]] and in those who have [[HIV/AIDS]], but are otherwise well.<ref name=WHO2016>{{cite journal | vauthors = ((World Health Organization)) | title = Polio vaccines: WHO position paper β March, 2016 | journal = Weekly Epidemiological Record | volume = 91 | issue = 12 | pages = 145β68 | date = 2016 | pmid = 27039410 | hdl=10665/254399 | hdl-access = free }}</ref> However, the emergence of circulating vaccine-derived poliovirus (cVDPV), a form of the vaccine virus that has reverted to causing poliomyelitis, has led to the development of novel oral polio vaccine type 2 (nOPV2), which aims to make the vaccine safer and thus stop further outbreaks of cVDPV.<ref name="GPEI-nOPV2">{{Cite web|title=GPEI-nOPV2|url=https://polioeradication.org/nopv2/|access-date=1 August 2021|language=en-GB|archive-date=27 July 2021|archive-url=https://web.archive.org/web/20210727211943/https://polioeradication.org/nopv2/|url-status=live}}</ref> <!-- History, society and culture --> The first successful demonstration of a polio vaccine was by [[Hilary Koprowski]] in 1950, with a live [[Attenuated vaccine|attenuated virus]] that people drank.<ref name="Kowproski_obit">{{cite web | vauthors = Fox M | url = https://www.nytimes.com/2013/04/21/us/hilary-koprowski-developed-live-virus-polio-vaccine-dies-at-96.html | title = Hilary Koprowski, Who Developed First Live-Virus Polio Vaccine, Dies at 96 | work = [[The New York Times]] | date = 20 April 2013 | access-date = 8 September 2017 | archive-date = 25 August 2017 | archive-url = https://web.archive.org/web/20170825133630/http://www.nytimes.com/2013/04/21/us/hilary-koprowski-developed-live-virus-polio-vaccine-dies-at-96.html | url-status = live }}</ref> The vaccine was not approved for use in the United States, but was used successfully elsewhere.<ref name="Kowproski_obit"/> The success of an [[Inactivated vaccine|inactivated]] (killed) polio vaccine, developed by [[Jonas Salk]], was [[Announcement of Polio vaccine success|announced in 1955]].<ref name=WHO2016/><ref>{{cite book| vauthors = Bazin H |title=Vaccination: A History|date=2011|publisher=John Libbey Eurotext|isbn=978-2742007752|page=395|url=https://books.google.com/books?id=orjaA_7sYZQC&pg=PA395|url-status = live|archive-url=https://web.archive.org/web/20170908183608/https://books.google.com/books?id=orjaA_7sYZQC&pg=PA395|archive-date=8 September 2017}}</ref> Another attenuated live oral polio vaccine, developed by [[Albert Sabin]], came into commercial use in 1961.<ref name=WHO2016/><ref>{{cite journal|vauthors=Smith DR, Leggat PA|date=2005|title=Pioneering figures in medicine: Albert Bruce Sabin β inventor of the oral polio vaccine|journal=The Kurume Medical Journal|volume=52|issue=3|pages=111β116|doi=10.2739/kurumemedj.52.111|pmid=16422178|doi-access=free}}</ref> Polio vaccine is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO23rd">{{cite book | vauthors = ((World Health Organization)) | title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) | year = 2023 | hdl = 10665/371090 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2023.02 | hdl-access=free }}</ref> {{TOC limit|3}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)